NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), today reported financial and business highlights for the quarter and year ended December 31, 2014.
The Company operates in two primary markets - wearable therapeutic technology and point-of-care tests. It recently unveiled the Quell™ wearable pain relief device, which utilizes proprietary non-invasive neurostimulation technology to provide relief from chronic pain, particularly nerve pain such as due to diabetes and lower back problems.
Help employers find you! Check out all the jobs and post your resume.
The Company operates in two primary markets - wearable therapeutic technology and point-of-care tests. It recently unveiled the Quell™ wearable pain relief device, which utilizes proprietary non-invasive neurostimulation technology to provide relief from chronic pain, particularly nerve pain such as due to diabetes and lower back problems.
Help employers find you! Check out all the jobs and post your resume.
